Status:
COMPLETED
Preventing Rehospitalization in Lung Transplant Recipients Utilizing mHealth
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
University of California, San Francisco
Conditions:
Lung Transplant; Complications
Eligibility:
All Genders
18-76 years
Phase:
NA
Brief Summary
Lung transplantation has several important aims: 1) extend survival; 2) relieve disability, and 3) improve health-related quality of life (HRQL) for adults suffering from end-stage lung disease. Advan...
Detailed Description
Mission and Specific Aims: Lung transplantation has several important aims: 1) extend survival; 2) relieve disability, and 3) improve health-related quality of life (HRQL) for adults suffering from en...
Eligibility Criteria
Inclusion
- Lung transplant recipient
- SPPB score less than or equal to 9 OR a readmission within 30 days of lung transplant discharge
Exclusion
- SPPB \>9
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03792698
Start Date
January 15 2019
End Date
June 1 2020
Last Update
June 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104